Table 1.
Characteristics | |
Patients, n (eyes, n) | 74 (74) |
Sex (male:female) | 41:33 |
Treatment status (naïve:switched) | 17:57 |
Mean age ± SD (years) | 79.34 ± 2.83 |
Comorbilities, n of patients | |
None | 18 |
Hypertension | 27 |
Cardiovascular disease | 13 |
Diabetes | 10 |
Allergy | 12 |
MN Vtype, n of eyes (naïve:switched) | |
Type 1 | 37 (8:29) |
Type 2 | 23 (6:17) |
RAP | 3 (0:3) |
PCV | 5 (3:2) |
Mixed | 6 (1:5) |
Weeks of follow up (months), n of patients | |
36 (9) | 3 |
38 (9.5) | 6 |
42 (10.5) | 2 |
48 (12) | 35 |
54 (13.5) | 5 |
60 (15) | 10 |
72 (18) | 3 |
84 (21) | 3 |
≥ 92 (≥ 23) | 3 |
SD standard deviation, MNV macular neovascularization, RAP retinal angiomatous proliferation, PCV polypoidal choroidal vasculopathy.